# New Renal Insufficiency trials, last 30 days: 37 (2026)

Updated November 19, 2026.

37 new trials for Renal Insufficiency were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New Renal Insufficiency clinical trials, last 30 days: 37 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/new/renal-insufficiency

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 31
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946068 | Aleniglipron Renal Impairment Study | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 1 | Not yet recruiting | Renal Impairment, Severe Renal Impairment | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946068) |
| November 18, 2026 | NCT07945795 | RDN for CKD and Uncontrolled Hypertension Trial | Beijing Anzhen Hospital | Not applicable | Recruiting | Hypertension, CKD - Chronic Kidney Disease | 248 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945795) |
| November 16, 2026 | NCT07940205 | Machine-learning Algorithm for Prediction of CKD From Retinal Images | Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI) | Observational | Not yet recruiting | Chronic Kidney Disease, Hypertension, T2DM (Type 2 Diabetes Mellitus), eGFR | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940205) |
| November 16, 2026 | NCT07938034 | A Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal Function | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Phase 1 | Recruiting | Renal Impairment | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938034) |
| November 13, 2026 | NCT07934836 | Comparing Two Hemodialysis Systems in Adults Receiving Dialysis Twice a Week in Yogyakarta, Indonesia | Bethesda Hospital Yogyakarta | Not applicable | Completed | Hemodialysis, End Stage Chronic Renal Failure | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934836) |
| November 12, 2026 | NCT07933848 | A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal Impairment | Pfizer | Phase 1 | Not yet recruiting | Renal Impairment, Healthy Adults | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933848) |
| November 12, 2026 | NCT07932483 | Manual Lymphatic Drainage Versus Classical Massage on Heart Responses and Mood in Hemodialysis | Mersin University | Not applicable | Not yet recruiting | Renal Dialysis, Renal Insufficiency, Chronic, Manual Lymphatic Drainage, Massage, Affect (Mental Function) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932483) |
| November 12, 2026 | NCT07932184 | Different Exercise Modalities in Chronic Kidney Disease: A Longitudinal Intervention Study | China Institute of Sport Science | Not applicable | Not yet recruiting | Chronic Kidney Disease (CKD), Renal Dysfunction | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932184) |
| November 12, 2026 | NCT07931911 | TOMO-QALY: Peer Mentoring in Chronic Kidney Disease | University Hospital, Caen | Not applicable | Not yet recruiting | Renal Insufficiency, Chronic, Peer Group | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931911) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 12, 2026 | NCT07930598 | Kidney Function Following Living Kidney Donation | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Observational | Active not recruiting | Nephrectomy,Kidney Donation, Living Kidney Donor, ESKD, Kidney Failure | 55,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930598) |
| November 10, 2026 | NCT07930169 | Observational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in Progressive Chronic Kidney Disease Patients. | HK inno.N Corporation | Observational | Recruiting | Chronic Kidney Disease | 3,125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930169) |
| November 10, 2026 | NCT07927959 | Clinical Pharmacist-Led Cardiovascular Risk Assessment in Patients With Chronic Kidney Disease (CRICKD) | Marmara University | Not applicable | Completed | Chronic Kidney Disease (CKD), Cardiovascular (CV) Risk, Quality of Lifte, Medication Adherence | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927959) |
| November 10, 2026 | NCT07927478 | Transcutaneous Auricular Vagal Neuromodulation Therapy (AVNT™) in Chronic Kidney Disease Autonomic Dysfunction | NYU Langone Health | Not applicable | Not yet recruiting | Chronic Kidney Disease (CKD) Stages G3 to G5 | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927478) |
| November 9, 2026 | NCT07925502 | Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit | Xeltis | Not applicable | Not yet recruiting | End Stage Renal Failure, Hemodialysis | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925502) |
| November 9, 2026 | NCT07924930 | A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function | Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company | Phase 1 | Not yet recruiting | Renal Insufficiency, Healthy Participant | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924930) |
| November 6, 2026 | NCT07923071 | A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment | Syndax Pharmaceuticals | Phase 1 | Not yet recruiting | Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia, Relapsed Leukemia | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923071) |
| November 6, 2026 | NCT07922889 | Mesenchymal Stem Cell Exosomes Alone or Combined With HUVEC Exosomes in Non-Dialysis Chronic Kidney Disease | Sponsor not shown (see the record) | Phase 1/2 | Completed | Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4, Chronic Kidney Disease | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922889) |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922772) |
| November 6, 2026 | NCT07922174 | A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013) | Merck Sharp & Dohme LLC | Phase 1 | Not yet recruiting | Healthy, Renal Impairment | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922174) |
| November 6, 2026 | NCT07921342 | An Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care | Brigham and Women's Hospital | Not applicable | Not yet recruiting | Chronic Kidney Diseases | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921342) |
| November 6, 2026 | NCT07920926 | Hypothermic Kidney Machine Perfusion With Omnisol | Vivalyx GmbH | Not applicable | Not yet recruiting | End Stage Renal Disease (ESRD), Kidney Transplant, Kidney Failure, Renal and Urinary Tract Therapeutic Procedures | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920926) |
| November 5, 2026 | NCT07918508 | Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health | Florida International University | Not applicable | Not yet recruiting | Hypertension (HTN), CKD - Chronic Kidney Disease, Cardio-Renal Syndrome, Food Insecurity, Type 2 Diabetes | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918508) |
| November 3, 2026 | NCT07914075 | Kidney Stiffness Measured by Ultrasound in Patients With High Blood Pressure and Healthy Volunteers | Azienda Ospedaliera di Padova | Observational | Recruiting | Arterial Hypertension, Chronic Kidney Disease, Primary Aldosteronism, Arterial Stenosis | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914075) |
| November 3, 2026 | NCT07912359 | Effect of Synbiotic Therapy on Renal Function Outcomes in Patients With Chronic Kidney Disease Stage III-IV: A Double-blind Randomized... | Chittagong Medical College | Not applicable | Recruiting | Chronic Kidney Disease (Stage 3-4) | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912359) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 7 |
| Phase 1/2 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
| Not applicable | 20 |
| Observational | 5 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 2 |
| Universitas Indonesia | 2 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 1 |
| Beijing Anzhen Hospital | 1 |
| Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI) | 1 |
| [CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.](https://specstream.ai/data/clinical-trials/company/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd) | 1 |
| Bethesda Hospital Yogyakarta | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| Mersin University | 1 |
| China Institute of Sport Science | 1 |
| University Hospital, Caen | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| [HK inno.N Corporation](https://specstream.ai/data/clinical-trials/company/hk-inno-n-corporation) | 1 |
| Marmara University | 1 |
| NYU Langone Health | 1 |
| Xeltis | 1 |
| Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company | 1 |
| [Syndax Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/syndax-pharmaceuticals) | 1 |
| University of Michigan | 1 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| Brigham and Women's Hospital | 1 |
| Vivalyx GmbH | 1 |
| Florida International University | 1 |
| Azienda Ospedaliera di Padova | 1 |
| Chittagong Medical College | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mongolian restaurants in the United States](https://specstream.ai/data/businesses/mongolian-restaurants/united-states)
- [Pan Asian restaurants in the United States](https://specstream.ai/data/businesses/pan-asian-restaurants/united-states)
- [Portuguese restaurants in the United States](https://specstream.ai/data/businesses/portuguese-restaurants/united-states)
- [Remodeling contractors in the United States](https://specstream.ai/data/businesses/remodeling-contractors/united-states)
- [Software development companies in the United States](https://specstream.ai/data/businesses/software-development-companies/united-states)
- [Test preparation centers in the United States](https://specstream.ai/data/businesses/test-preparation-centers/united-states)
